Skip to main content

The EPA Is Funding Research On Using Hemp As A Sustainable Alternative To Concrete

Popular cult classics like The Big Lebowski would have you believe that people who use marijuana not only always have the munchies, but they’re also too lazy to engage in a lot of physical activity.

With those kinds of stereotypes pervading movies and TV shows, it makes sense that many people would assume marijuana use is positively associated with weight gain.

But a new study published last week in the International Journal of Epidemiology appears to undermine that belief. It’s the latest research to show that marijuana users are actually less likely to be obese compared to non-users.

For their work, Michigan State University researchers drew on data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), a cross-sectional, nationally representative study sample of U.S. citizens aged 18 and older. In total, they looked at the reported responses of more than 33,000 people.

In the first wave of interviews completed in 2001-2002, participants were asked if they used cannabis and, if so, how recently and how frequently. When they returned for their follow-up interview in 2004-2005, researchers asked participants if they used cannabis since that first interview.

Between the two interview periods, researchers tracked an increase in body mass index (BMI) in all categories of respondents—those who’d never consumed, people who had discontinued past use, “initiates” or newbies and persistent users.

Once they excluded participants who were older than 65 (because research shows BMI declines in older people are often due to loss of muscle mass), they discovered “an attenuated BMI gain for cannabis-use subgroups when compared with never-users.”

In other words, those who reported using marijuana gained weight, but at a reduced rate compared to those who have never consumed cannabis.

“In NESARC, persistent cannabis users and the initiates were under-represented in stably obese subgroups,” the study states. “In addition, these same actively cannabis-using subgroups were under-represented among newly incident cases of obesity observed at W2.”

The study offers a couple of theories to explain why marijuana users experience lower weight gain. One, for example, has to do with how the density of a specific cannabinoid receptor (CB1R) decreases with chronic cannabis use. It’s a theory that was first introduced last year by a separate team of researchers at Indiana University South Bend.

“For many patients,” they wrote in the meta-analysis they published in December, “Cannabis may be a better option for weight loss than surgery or pharmaceuticals.”

Why Marijuana Consumers Have Smaller Waistlines Than Non-Users

Another possibility to explain the relationship between marijuana use and BMI has to do with the anti-inflammatory properties of another cannabinoid receptor, CB2R. “The association of inflammation and obesity is widely established in pre-clinical and clinical studies,” the study’s authors write.

These findings are important for future biomedical research regarding cannabinoids—especially since medical marijuana is often toted as a potential treatment for preventing weight loss in HIV and cancer patients, the study states.

The average cannabis consumer concerned about their waistline might also find a little bit of comfort in these results, too—especially since other research has indicated that states with legal marijuana saw an increase in junk food purchases.

Scientists Actually Did A Study To Confirm That Marijuana Causes The Munchies

Photo courtesy of Philip Steffan.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Original Article Source: https://www.marijuanamoment.net/the-epa-is-funding-research-on-using-hemp-as-a-sustainable-alternative-to-concrete/

Comments

Post a Comment

Popular posts from this blog

Feds Hire Hazmat Firm For Marijuana Eradication Training

An ambitious campaign to decriminalize psychedelics in Washington, D.C., is one step closer to placing their measure on the November ballot with the formal submission of tens of thousands of voter signatures. Organizers have been scrambling for weeks to collect enough signatures from D.C. voters by Monday’s deadline amid historically difficult circumstances: a global pandemic, months of stay-at-home orders and protests over racism and police violence that filled the streets of the nation’s capital. But with the help of innovative signature-gathering techniques and allies flown in from across the country, advocates said they had successfully submitted upwards of 35,000 signatures—more than enough to qualify the initiative. If approved by voters, Initiative 81 would make enforcement of laws against plant- and fungus-based psychedelics among the “lowest law enforcement priorities” for the Metropolitan Police Department. It would not, however, legalize or reduce penalties for the substa...
Post a Comment
Read more

FDA Warns 15 Companies For Illegally Selling CBD Products

The agency also released a consumer update about CBD , the non-psychoactive ingredient in marijuana increasingly used to treat pain and anxiety. Until it learns more about the effectiveness and safety of CBD, the FDA said it cannot generally recognize the ingredient as safe or approve products that contain it. “We remain concerned that some people wrongly think that the myriad of CBD products on the market, many of which are illegal, have been evaluated by the FDA and determined to be safe, or that trying CBD ‘can’t hurt,‘” FDA Principal Deputy Commissioner Amy Abernethy said. The FDA sent letters to the following 15 companies for selling CBD products that violate the Food, Drug and Cosmetic Act, for marketing the products to treat illnesses or for therapeutic use, claiming it’s a dietary supplement or adding it to food for humans and animals. -Red Pill Medical Inc. of Phoenix, Arizona -Pink Collections Inc. of Beverly Hills, California -Healthy Hemp Strategies LLC (does ...
Post a Comment
Read more

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...
Post a Comment
Read more